Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-arginine and L-citrulline for Fetal Growth Retardation
NCT05029778Phase 4Unknown
- Sponsor
- Hospital Civil de Guadalajara
- Start
- Oct 2021
- Primary completion
- Oct 2021
01
Overview
Phase 4, randomised, double-blind trial in fetal growth restriction (FGR), sponsored by Hospital Civil de Guadalajara. Primary endpoint: Fetal Growth at 10 weeks. Status: unknown.
02
Conditions
fetal growth restriction (FGR)
Beyond the preview
Go deeper on NCT05029778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05029778.